AI Article Synopsis

  • Hypertension raises the risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease, but targeting the renin-angiotensin-aldosterone system (RAAS) can help lower blood pressure and reduce these risks.
  • Research indicates that RAAS inhibitors, particularly ACE inhibitors and angiotensin receptor blockers, can decrease the incidence of T2DM while also providing kidney protection and cardiovascular benefits.
  • Despite promising results from various trials, more randomized controlled studies are needed to clarify how RAAS inhibitors can specifically contribute to diabetes prevention.

Article Abstract

Hypertension increases the risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease. In addition to lowering blood pressure, blockade of the renin-angiotensin-aldosterone system (RAAS) reduces the risk of new-onset T2DM and offers renal protection. Using a MEDLINE search, we identified multiple trials that reported the incidence of T2DM in patients taking inhibitors of RAAS. In this review, we will discuss the RAAS as a potential target in diabetes prevention and the mechanisms through which inhibitors of this system achieve such an important effect. We will also shed light on the beneficial cardiovascular and renal effects of RAAS blockade. Although multiple studies have demonstrated that inhibitors of RAAS, especially angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, can reduce the incidence of T2DM, randomized controlled studies are still needed to further elucidate their exact role in diabetes prevention.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1463-1326.2008.00898.xDOI Listing

Publication Analysis

Top Keywords

diabetes prevention
12
cardiovascular renal
8
renal protection
8
incidence t2dm
8
inhibitors raas
8
raas
5
role renin-angiotensin-aldosterone
4
renin-angiotensin-aldosterone system-based
4
system-based therapy
4
diabetes
4

Similar Publications

Role of antioxidative stress activity of Fucoxanthin nanoparticle as hepatoprotective in diabetic rats.

Pak J Pharm Sci

January 2025

Department of Basic Veterinary Medicine, Faculty of Veterinary Medicine, Airlangga, University, Surabaya, Indonesia.

This study attempts to prove that the antioxidant effect of fucoxanthin nanoparticles can prevent streptozotocin-induced rat liver damage. Fucoxanthin nanoparticles are synthesized using the high-energy ball milling method. Dynamic Light Scattering (DLS) was then used to describe the sizes of the fucoxanthin nanoparticles.

View Article and Find Full Text PDF

Association between four anthropometric indices with age-related Macular Degeneration from NHANES 2005-2008.

Lipids Health Dis

January 2025

Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, People's Republic of China.

Background: Age-related macular degeneration (AMD) decrease vision and presents considerable challenges for both public health and clinical management strategies. Obesity is usually implicated with increased AMD, and body mass index (BMI) does not reflect body fat distribution. An array of studies has indicated a robust relationship between body fat distribution and obesity.

View Article and Find Full Text PDF

Burden of intestinal parasites among diabetic patients in Africa: a systematic review and meta-analysis.

BMC Infect Dis

January 2025

Department of Medical Laboratory Science, College of Health Sciences, Woldia University, P.O. box 400, Woldia, Ethiopia.

Background: Intestinal parasite infections remain a serious public health concern around the world, particularly in countries with inadequate sanitation. The study aims to ascertain the total magnitude of intestinal parasites in diabetes patients throughout the African countries.

Objective: The aim of this systematic review and meta-analysis was to determine the general burden of intestinal parasites among diabetic patients in Africa.

View Article and Find Full Text PDF

Impact of postoperative morbidity on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: a multicenter observational study.

Sci Rep

January 2025

Department of Comprehensive Surgery, Vascular Surgery, Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, 666 Shengli Road, Chongchuan District, Nantong City, 226014, Jiangsu Province, China.

The long-term impact of postoperative morbidity following laparoscopic liver resection for hepatocellular carcinoma is unclear. This study aimed to investigate whether the prognosis of hepatocellular carcinoma patients were affected by postoperative morbidity after laparoscopic liver resection. Hepatocellular carcinoma patients who underwent curative-intent laparoscopic liver resection were included.

View Article and Find Full Text PDF

GWAS of CRP response to statins further supports the role of APOE in Statin Response: a GIST consortium study.

Pharmacol Res

January 2025

Centre of Clinical Pharmacology & Precision Medicine, William Harvey Research Institute, Queen Mary University of London, London, UK; NIHR Barts Biomedical Research Centre, Queen Mary University of London, London, UK. Electronic address:

Statins are first-line treatments in the primary and secondary prevention of cardiovascular disease. Clinical studies show statins act independently of lipid-lowering mechanisms to decrease C-reactive protein (CRP), an inflammation marker. We aim to elucidate genetic loci associated with CRP statin response.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!